Krystal Biotech to Present at H.C. Wainwright 26th Annual Global Investment Conference

Rhea-AI Summary

Krystal Biotech (NASDAQ: KRYS), a commercial-stage biotechnology company, has announced its participation in the H.C. Wainwright 26th Annual Global Investment Conference on September 10, 2024, in New York. Krish S. Krishnan, Chairman and CEO, will deliver a company presentation at 12:30 pm ET and engage in investor meetings throughout the day.

A webcast of the presentation will be available starting at 12:30 pm ET on Tuesday, September 10, 2024, accessible through a provided link and subsequently posted on the Investors section of the company's website. This event presents an opportunity for Krystal Biotech to showcase its progress and engage with potential investors in a prominent global investment forum.

PITTSBURGH, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that the Company will participate in the H.C. Wainwright 26th Annual Global Investment Conference on September 10, 2024, in New York. Krish S. Krishnan, Chairman and Chief Executive Officer, is scheduled to give a company presentation at 12:30 pm ET and host investor meetings throughout the day.

A webcast of the presentation will be available here beginning at 12:30 pm ET on Tuesday, September 10, 2024 and will be posted on the Investors section of the Company’s website.

About Krystal Biotech, Inc.

Krystal Biotech, Inc. (NASDAQ: KRYS) is a commercial-stage biotechnology company focused on the discovery, development and commercialization of genetic medicines to treat diseases with high unmet medical needs. VYJUVEK^® is the Company’s first commercial product, the first-ever redosable gene therapy, and the first medicine approved by the FDA for the treatment of dystrophic epidermolysis bullosa. The Company is rapidly advancing a robust preclinical and clinical pipeline of investigational genetic medicines in respiratory, oncology, dermatology, ophthalmology, and aesthetics. Krystal Biotech is headquartered in Pittsburgh, Pennsylvania. For more information, please visit http://www.krystalbio.com, and follow @KrystalBiotech on LinkedIn and X (formerly Twitter).

CONTACT
Investors and Media:
Stéphane Paquette
Krystal Biotech
spaquette@krystalbio.com

FAQ

When is Krystal Biotech (KRYS) presenting at the H.C. Wainwright Global Investment Conference?

Krystal Biotech (KRYS) is presenting at the H.C. Wainwright 26th Annual Global Investment Conference on September 10, 2024, at 12:30 pm ET in New York.

Who will be representing Krystal Biotech (KRYS) at the H.C. Wainwright conference?

Krish S. Krishnan, Chairman and Chief Executive Officer of Krystal Biotech, will be giving the company presentation and hosting investor meetings at the conference.

How can investors access Krystal Biotech's (KRYS) presentation at the H.C. Wainwright conference?

A webcast of Krystal Biotech's presentation will be available starting at 12:30 pm ET on September 10, 2024, through a provided link and will later be posted on the Investors section of the company's website.

What type of company is Krystal Biotech (KRYS)?

Krystal Biotech (KRYS) is described as a commercial-stage biotechnology company in the press release.